Access cutting-edge chronic kidney disease treatment through this clinical trial at a research site in Live Oak. Study-provided care at no cost to qualified participants.
Access chronic kidney disease specialists in Live Oak at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic kidney disease treatment provided free
This trial is an investigator-initiated, multi-center, randomized (1:1), open-label, active-controlled, pragmatic study of the safety of vadadustat administered three times per week for the treatment of anemia in in-center hemodialysis patients with End Stage Kidney Disease (ESKD). This study will obtain long-term safety data in a large sample of subjects receiving in-center hemodialysis to support adoption of three times per week vadadustat dosing.
Sponsor: USRC Kidney Research
Check if you qualify for this chronic kidney disease clinical trial in Live Oak, TX
If you're searching for chronic kidney disease treatment options in Live Oak, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Live Oak research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic kidney disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.